Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewInternational Clinical Trials Day: Driving healthcare innovation through Artificial Intell...
The TerminAI project aims to optimize healthcare data management through artificial intelligence, enhancing the efficiency and accuracy of clinical information coding.
-
Press releaseInternational Clinical Trials Day: Driving healthcare innovation through Artificial Intell...
Spain positions itself as a European leader in clinical trials, while facing challenges such as improving clinical data coding and increasing investment in R&D. The TerminAI project aims to optimize
-
CompanyBIODURO
-
-
CompanyDISRUPT THERAPEUTICS
-
New#NewAseBioMember | “AseBio is the meeting point for all companies that aim to contribute t...
Meet our new member MedBioinformatics. We sponke with Patricia Ortega Muñoz, CEO and Medical Director.
-
NewPrevention versus Therapy. The breakthrough of the current century
Massive data collection accelerated by the digitisation of healthcare, as well as artificial intelligence, is becoming an essential pillar for prevention.
-
NewBiomedical innovation 'made in Spain': Challenges and opportunities in the long race to ma...
Experts from the sector highlighted at the 18th Annual Conference of the Biomedical Research Technology Platforms the need to promote effective mechanisms for support, funding, and collaboration to
-
Press release
Biomedical innovation 'made in Spain': Challenges and opportunities in the long race to ma...
Experts from the sector highlighted at the 18th Annual Conference of the Biomedical Research Technology Platforms the need to promote effective mechanisms for support, funding, and collaboration to
-
CompanyMICROVIABLE THERAPEUTICS
-
NewORYZON awarded 13.26 million € through the first Important Project of Common European Inte...
Oryzon to validate epigenetic agents by applying a personalized medicine approach for rare and orphan diseases.
-
NewTheriva™ Biologics Announces Primary Endpoints for Efficacy and Safety Achieved in VIRAGE ...
Patients treated with VCN-01 (zabilugene almadenorepvec) plus gemcitabine/nab-paclitaxel standard-of-care (SoC) chemotherapy had increased overall survival, progression free survival, and duration of
-
-
NewNuage Therapeutics, Ona Therapeutics, and SpliceBio are leading the wave of biotech innova...
Las biotecnológicas Nuage Therapeutics, Ona Therapeutics y SpliceBio, con sede en el Parque Científico de Barcelona, han sido destacadas en un reciente artículo de la revista 'Nature' como referentes
-
NewNatac closes 2024 with record sales of nearly 36 million euros
The company increased its normalized EBITDA by 47%, reaching €13.82 million.
-
-
-
-
New#NewAseBioMember | "We believe that AseBio can serve as an important tool for expanding co...
Meet our new member MedBioinformatics. We sponke with Ferran Sanz, Founding Partner, Member of the Board of Directors, and Scientific Advisor
-
CompanyLEANBIO
-
